Hepatobiliary disorders among naïve patients with ulcerative colitis in Upper Egypt

Arab Journal of Gastroenterology

Volumn 13, Issue 2, 2012, Pages 71-76

  Morsy, Khairy Hammam ^a   Hasanain, Ahmad Farooq Alsayed ^a  

^a ASSIUT UNIVERSITY   (Egypt)

Author keywords

Egypt; Hepatobiliary disorders; Ulcerative colitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GLUCOSE;

ABDOMINAL RADIOGRAPHY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CELL COUNT; CHOLELITHIASIS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ECHOGRAPHY; ENDOSCOPY; ERYTHROCYTE SEDIMENTATION RATE; FATTY LIVER; FEMALE; HEPATOBILIARY DISEASE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; JAUNDICE; LABORATORY TEST; MALE; MEDICAL HISTORY; PALLOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGE FACTORS; COLITIS, ULCERATIVE; CONFIDENCE INTERVALS; EGYPT; FATTY LIVER; FEMALE; GALLBLADDER; GALLSTONES; HUMANS; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84866291759     PISSN: 16871979     EISSN: 20902387     Source Type: Journal    
DOI: 10.1016/j.ajg.2012.06.005     Document Type: Article

References (13)

1. Wewer V., Gluud C., Schlichting P., et al. Prevalence of hepatobiliary dysfunction in a regional group of patients with chronic inflammatory bowel disease. Scand J Gastroenterol 1991, 26(1):97-102.
2. Bargiggia S., Maconi G., Elli M., et al. Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: study of 511 subjects at a single center. J Clin Gastroenterol 2003, 36(5):417-420.
3. Ong J.C., O'Loughlin E.V., Kamath K.R., et al. Sclerosing cholangitis in children with inflammatory bowel disease. Aust N Z J Med 1994, 24(2):149-153.
4. Yamamoto Furusho J.K., Sánchez Osorio M., Uribe M. Prevalence and factors associated with the presence of abnormal function liver tests in patients with ulcerative colitis. Ann Hepatol 2010, 9(4):397-401.
5. Mattila J., Aitola P., Matikainen M. Liver lesions found at colectomy in ulcerative colitis: Correlation between histological findings and biochemical parameters. J Clin Pathol 1994, 47(11):1019-1021.
6. Kurchin A., Ray J.E., Bluth E.I. Cholelithiasis in Ileostomy patients. Dis Colon Rectum 1984, 27(9):585-588.
7. Silverberg M.S., Satsangi J., Ahmad T., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl. A):5-36.
8. Schroeder K.W., Tremaine W.J., Ilstrup D.M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study. N Engl J Med 1987, 317(26):1625-1629.
9. Dew M.J., Thompson H., Allan R.N. The spectrum of hepatic dysfunction in inflammatory bowel disease. Q J Med 1979, 48(189):113-135.
10. Broomé U., Glaumann H., Hellers G., et al. Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm. Gut 1994, 35(1):84-89.
11. Ahmad J., Slivka A. Hepatobiliary disease in inflammatory bowel disease. Gastroenterol Clin North Am 2002, 31(1):329-345.
12. Lorusso D., Leo S., Mossa A., et al. Cholelithiasis in inflammatory bowel disease. a case-control study. Dis Colon Rectum 1990, 33(9):791-794.
13. Chitturi S., Abeygunasekera S., Farrell G.C., et al. NASH and insulin resistance. insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002, 35(2):373-379.